Article
Myostatin inhibition: a potential performance enhancement strategy?
3 Feb 2008
Abstract excerpt
A decade has passed since myostatin was first identified as a negative regulator of muscle growth. Since then, studies in both humans and animals have demonstrated that decreasing the levels of this growth factor or inhibiting its function can dramatically increase muscle size, and a number of therapeutic applications of myostatin inhibition to the treatment of myopathies and muscle atrophy have been proposed. As...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
